Literature DB >> 12658550

Family history and reading habits in adult-onset myopia.

Rafael Iribarren1, Guillermo Iribarren, Maria M Castagnola, Alejandra Balsa, Mario R Cerrella, Alejandro Armesto, Andrea Fornaciari, Tomás Pförtner.   

Abstract

PURPOSE: A retrospective study was developed to evaluate risk factors in adult-onset myopia.
METHODS: Subjects included were 25 to 35 years old. There were 116 non-myopic subjects in the control group and 66 myopic subjects with first lens prescription at age 17 or later. Subjects received a questionnaire about academic achievement, daily hours of reading during years of study, and family history of myopia.
RESULTS: The level of academic achievement was similar for myopic and non-myopic groups in this sample. Myopia was associated with family history (chi(2) = 6.131, p </= 0.013) and with daily hours of reading during years of study (chi(2) = 3.904, p </= 0.048). According to multiple logistic regression analysis, the correlation of myopia with family history adjusted for daily hours of reading remained significant (p </= 0.005), whereas the correlation with daily hours of reading adjusted for family history was not significant (p </= 0.061).
CONCLUSIONS: After multivariate analysis, adult-onset myopia was significantly associated only with family history of myopia.

Entities:  

Mesh:

Year:  2002        PMID: 12658550     DOI: 10.1076/ceyr.25.5.309.13494

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  Adult onset unilateral high myopia in a female patient: A case report.

Authors:  Saleh Saif Al Messabi; Mohamed Dirani; Shobhana Mukhi-Marathe
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-29

2.  Early Age of the First Myopic Spectacle Prescription, as an Indicator of Early Onset of Myopia, Is a Risk Factor for High Myopia in Adulthood.

Authors:  Wei-Yu Chiang; Yun-Wen Chen; Yu-Peng Liu; Yung-Hsun Liu; Pei-Chang Wu
Journal:  J Ophthalmol       Date:  2021-06-22       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.